TreeFrog Therapeutics is a stem cell company that will enable millions of patients to access the medical revolution of cell therapies.
TreeFrog Therapeutics has raised $34.0M in total funding. The most recent round was Debt Financing. The last funding was announced in May 2025.
TreeFrog Therapeutics's investors include European Investment Bank, Bpifrance, Leonard Green & Partners, Bristol-Myers Squibb, XAnge.
TreeFrog Therapeutics is headquartered in Bordeaux, France.
TreeFrog Therapeutics is a stem cell company that will enable millions of patients to access the medical revolution of cell therapies.
TreeFrog Therapeutics is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TreeFrog Therapeutics — Funding & Investors." VCBacked, May 27, 2025, https://www.vcbacked.co/company/treefrog-therapeutics. Accessed July 22, 2026.
VCBacked. (2025). TreeFrog Therapeutics — Funding & Investors. Retrieved July 22, 2026, from https://www.vcbacked.co/company/treefrog-therapeutics
{{cite web |title=TreeFrog Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/treefrog-therapeutics |website=VCBacked |access-date=July 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated